# A Clinical Study of GO321 in Patients With Advanced Solid Tumors

> **NCT07748117** · PHASE1 · NOT_YET_RECRUITING · sponsor: **GeneSail Biotech (Shanghai) Co., Ltd.** · enrollment: 21 (estimated)

## Conditions studied

- Solid Tumor Malignancies

## Interventions

- **DRUG:** GO321

## Key facts

- **NCT ID:** NCT07748117
- **Lead sponsor:** GeneSail Biotech (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748117, "A Clinical Study of GO321 in Patients With Advanced Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*